ABSTRACT Many RNA viruses are detected by retinoic acid-inducible gene i (RIG-I), a cytoplasmic sensor that triggers an antiviral response upon binding non-self-RNA that contains a stretch of double-stranded RNA (dsRNA) bearing a base-paired 5= ppp nucleotide. To gain insight into how RIG-I discriminates between self-RNA and non-self-RNA, we used duplexes whose complementary bottom strand contained both ribo-and deoxynucleotides. These duplexes were examined for their binding to RIG-I and their relative abilities to stimulate ATPase activity, to induce RIG-I dimerization on the duplex, and to induce beta interferon (IFN-␤) expression. We show that the chemical nature of the bottom strand is not critical for RIG-I binding. However, two key ribonucleotides, at positions 2 and 5 on the bottom strand, are minimally required for the RIG-I ATPase activity, which is necessary but not sufficient for IFN-␤ stimulation. We find that duplexes with shorter stretches of dsRNA, as model self-RNAs, bind less stably to RIG-I but nevertheless have an enhanced ability to stimulate the ATPase. Moreover, ATPase activity promotes RIG-I recycling on RIG-I/dsRNA complexes. Since pseudo-self-RNAs bind to RIG-I less stably, they are preferentially recycled by ATP hydrolysis that weakens the helicase domain binding of dsRNA. Our results suggest that one function of the ATPase is to restrict RIG-I signaling to its interaction with non-self-RNA. A model of how this discrimination occurs as a function of dsRNA length is presented.
domains to close and form an ATP binding pocket. This in turn leads to the exposure of the CARDs, which are now available for downstream signaling. The precise role of ATP binding and hydrolysis in this process, however, remains unclear.
A better understanding of the RNA features required for its binding to, and activation of, RIG-I would shed light on the molecular signatures of a viral infection and on the capacity of RIG-I to discriminate between self-RNA and non-self-RNA and would refine the conception of the mechanism of RIG-I activation. Viruses have developed strategies to prevent RIG-I activation. One of these strategies is to minimize their visibility, i.e., to limit their detection by generating viral RNAs that mimic cellular RNAs. The result is never perfect, and cells have developed mechanisms that exploit the remaining differences. One aim of this study was to characterize the differences that are important in detection of viral pathogen-associated molecular patterns (PAMPs) by RIG-I. The work focuses on the role of the bottom strand of short RNA duplexes in RIG-I activation. We confirm the importance of the 5= ppp structure for RIG-I binding and demonstrate that the nature of the bottom strand (ribo-or deoxyribonucleotides) is not critical for binding. In contrast, the nature of this bottom strand is essential for the ATPase activity. Two key ribonucleotides, at positions 2 and 5, are minimally required for ATPase activity, which is further modulated by nucleotides between positions 6 and 13. Although dispensable for RNA binding, this ATPase activity is found to be required for RIG-I/dsRNA recycling, and this recycling occurs preferentially on short dsRNAs that are more similar to cellular RNAs. In cells, IFN-␤ induction requires a minimum RNA duplex of 13 bp. However, when cells are first primed with IFN-␤, the minimum duplex length is reduced to 8 to 10 bp: this shift in pattern recognition highlights the profound changes induced by IFN in response to viral infection.
RESULTS
A base-paired 5= ppp dsRNA structure is required for RIG-I binding, irrespective of the bottom-strand composition. The first prerequisite for RIG-I activation is RNA binding. To explore the contribution of the dsRNA bottom strand in this step, we performed RNA pulldown assays using different dsRNAs. The top (5= ppp) strand was made in vitro using a DNA template devoid of A residues in a T7 RNA polymerase reaction mixture lacking UTP. This prevents formation of contaminating dsRNA, as T7 RNA polymerase can also use the newly formed RNA as a template (20, 21 ) (see Materials and Methods). The 5= ppp single-stranded RNA The principal RNA hybrids used in this work are shown at the left side of the table, and their respective activities in the different tests used in this study are shown on the right. Numbers in the EMSA column represent the maximum numbers of RIG-I molecules found bound to the corresponding RNA. Black stands for ribonucleotides, and gray stands for deoxyribonucleotides. Unless specified by 5= OH, all the hybrids carry a 5= ppp (represented by black dots). RNA hybrids are named according to their length and composition in ribo-and deoxyribonucleotide of the bottom strand. RNAs highlighted in gray represent the key molecules supporting our conclusions.
(ssRNA) was then annealed with various synthetic (5= OH) bottom strands (Table 1) . These dsRNAs are named according to their bottom strand, whose length is 20 nucleotides (unless otherwise indicated) ( Table 1) . As previously shown, RNA binding to RIG-I required a 5= ppp in the context of a double-stranded structure, as neither 5= OH-dsRNA nor 5= ppp-ssRNA was efficiently bound (Fig. 1A and D) (7, (9) (10) (11) . This 5= ppp nucleotide must be base paired, as a 5= overhang strongly decreased binding whereas a 3= overhang was tolerated (Fig. 1B) . Consistent with this, an RNA hybrid with a mismatch at position 1 (30r mis.1) bound much less effectively to RIG-I (Fig. 1E) . The nature of the bottom strand appears not to be important, since hybrids containing a full deoxyribonucleotide bottom strand (20d; Fig. 1D ) and a chimeric bottom strand, composed of both ribo-and deoxyribonucleotides (5r-15d to 60r; Fig. 1C ), all bound similarly to RIG-I. In agreement with previous results (4, 22, 23) , we observed that the CTD was the main determinant for binding to our hybrid duplexes. Consistently, removal of the CARDs (⌬N; see have biased the result). Taken together, these results argue for end recognition by the RIG-I CTD of duplexes with a base-paired 5= ppp nucleotide, regardless of the nature of the bottom strand. Given that RIG-I helicase mutants lacking ATPase activity (K270A and D372A; see Fig. S2C ) still bind RNA (see Fig. S1C and D), the results indicate that ATPase activity is not required for binding. Key residues on the bottom strand are involved in RIG-I ATPase activity. ATPase is required for RIG-I activation (5; reviewed in reference 2). However, its role in RIG-I activation is still unclear, and the precise residues on the bottom strand involved in ATPase activity are unknown. In order to identify the minimal requirements for RIG-I ATPase activity, we tested our hybrids in an ATPase assay. In line with its requirement for RNA binding, the CTD is necessary for the ATPase activity (24 and data not shown). Additionally, and in agreement with results of pulldown experiments, a base-paired end is also required, as molecules with a 5= overhang or a mismatch at position 1 or ssRNA exhibited decreased ATPase activity ( Fig. 2B and G) . Surprisingly, in marked contrast to pulldown experiments that measure stable binding, the 5= ppp was not essential for ATPase activity in vitro, since a 5= OH duplex was as efficient ( Fig. 2A ; see also Fig. S2A in the supplemental material). In this case, since the 5= ppp is necessary for the stability of the RNA/RIG-I complex in pulldown assays and subsequent IFN-␤ stimulation, stable RNA binding appears not to be required for in vitro ATPase activity (see Discussion). These results nevertheless emphasize the role of the CTD in interacting with the blunt end of the dsRNA (independently of the 5= ppp) as the initial step for ATPase activity.
In contrast to the binding requirements, key ribonucleotides on the bottom strand are needed for ATPase activity. A hybrid with a bottom strand made entirely of deoxyribonucleotides was a very poor inducer of the ATPase despite normal binding to RIG-I (20d, Fig. 2C ; see also Fig. S2A in the supplemental material). The effective binding of this duplex to RIG-I was confirmed by its ability to interfere with the ATPase activity induced by a bona fide dsRNA (see Fig. S2B ). Increasing the number of ribonucleotides on the bottom strand from its 3= end progressively increased ATPase activity until ϩ5 ribonucleotides (5r-15d) was reached, at which point it was equivalent to that triggered by pure dsRNA ( Fig. 2C ; see also Fig. S2A ). When these results are combined with those obtained for hybrids in which an RNA bottom strand contained increasing numbers of deoxyribonucleotides from the 3= end ( Fig. 2E ; see also Fig. S2A ), it appears that two residues, at positions 2 and 5, represent key residues for the recovery of normal ATPase activity. By testing more hybrids, we confirmed that these two ribonucleotides, in a background of deoxyribonucleotide bottom strand, are necessary and sufficient to restore ATPase activity (2*5*r-18d, Fig. 2D ; see also Fig. S2A ). According to structural data (16, 25) , this corresponds to the binding of HEL1 and HEL2 to ribonucleotides 2 and 5 of the bottom strand, respectively. As both RNA:RNA and RNA:DNA hybrids are A-type helices, this suggests that the helicase domains need to interact with these 2= hydroxyls for optimal ATPase activity.
Surprisingly, a further increase in the number of ribonucleotides on the bottom strand from 6 to 10, a length that corresponds to coverage by one RIG-I molecule (16, 18, 25, 26) , resulted in ATPase activity that was significantly enhanced relative to that promoted by pure dsRNA ( HEL2i domain. Remarkably, further lengthening of the bottom strand beyond 10 nucleotides led to a return to the ATPase levels promoted by pure dsRNA ( Fig. 2F ; see also Fig. S2A and Discussion).
Further components on the bottom strand are necessary for full RIG-I activation. The ultimate aim of the RIG-I pathway is the activation of downstream genes, such as IFN-encoding genes. To investigate the involvement of the bottom strand in this process, we tested our hybrids in A549 cells using reporter gene assays (Fig. 3A) . As ATPase is required for RIG-I activation, the 20d hybrid that is unable to induce ATPase did not activate IFN-␤ ( Fig. 3B and D ; see also Fig. S3A in the supplemental material). In addition, molecules with a low ATPase level, such as 2d-18r to 5d-15r, induced IFN-␤ to a lower extent than the reference RNA (Fig. 3D) . However, there was no strict correlation between the ability of the hybrids to induce ATPase and RIG-I activation. In particular, the 2*5*r-18d hybrid, which represents the minimal requirements for normal ATPase, did not induce IFN-␤ either in our reporter gene system (Fig. 3B ) or in A549 cells expressing green fluorescent protein (GFP) under the control of the IFN-␤ promoter (see also Fig. S3A ). The absence of IFN-␤ induction with this molecule was not due to its potential instability in vivo, since cotransfection with a bona fide RNA PAMP, the 2*5*r-18d hybrid, interfered with RIG-I activation and induced decreased IFN-␤ induction, as shown previously for the 5= overhang duplexes ( Fig. 3E) (37) . In this experiment, increasing the amount of transfected 20r RNA increased IFN-␤ stimulation. This was in marked contrast to cotransfection with 5= overhang or 2*5*r-18d molecules, which led to decreased IFN-␤ stimulation ( role of the ATPase under these conditions? One hypothesis could be that, if RIG-I binds a non-bona fide RNA PAMP (such as self-RNA), the ATPase activity functions in RIG-I recycling. In order to test this hypothesis, a simple competition experiment was performed. RNA pulldown assays were carried out in which Histagged RIG-I was first bound to biotinylated RNA and, in a second step, competed with an excess of the same non-biotinylated RNA in the presence of ATP with or without MgCl 2 ( Fig. 4A ) or in the presence and absence of both ATP and MgCl 2 ( Fig. 4B ). Mg 2ϩ , which coordinates the ␤ and ␥ phosphates of ATP in ATPases, is an essential cofactor for activity (28) (Fig. S4A in the supplemental material shows that there is no ATPase activity in the absence of MgCl 2 ). As shown in Fig. 4A , addition of MgCl 2 and, presumably, the resulting hydrolysis of ATP strongly increased RIG-I exchange on both the 10r-10d and 20r RNA duplexes. ATP and MgCl 2 by themselves had no effect on RIG-I binding in the absence of competitor as seen in Fig. 4B (lane 4 versus lane 3). RIG-I recycling is observed only when the RNA competitor is added (Fig. 4B ). As a control, the same experiments were carried out with the K270A RIG-I mutant that cannot hydrolyze ATP (see Fig. S2C in the supplemental material). Although the lysine of the Walker A motif, in combination with the main chain NH groups, is considered essential for ATP binding (29) , and this lysine directly contacts the ␥-PO4 of ATP (27), Peisley et al. have recently reported that K270A RIG-I nevertheless binds ATP in vitro (30) but presumably not with the same stability as the wild-type (wt) protein.
In this case, RIG-I exchange was found to occur readily, and equally in the presence and absence of MgCl 2 and ATP (Fig. 4) , presumably due to less stable binding. The notion that one function of the ATPase is to promote RIG-I recycling on the RNA is also consistent with the finding that even hybrids with enhanced ATPase activity remain inactive under basal conditions (Fig. 5A [minus IFN-␤] and data not shown).
The effect of IFN priming. Interestingly, the lack of IFN-␤ stimulation by many of our hybrids can be reversed if cells are treated with IFN-␤ (primed) before RNA transfection ( Fig. 5A and B). The 9r-11d and 10r-10d hybrids, inactive under unprimed conditions, become partially active after IFN priming (Fig. 5A) . Likewise, the 13r-7d and 20r duplexes also showed enhanced stimulation in cells primed with IFN-␤ ( Fig. 5A and B) . In contrast, duplexes with a mismatch at position 1 (30r mis.1), as in the Ebola virus genome panhandle (Zaire Ebola virus, complete genome, gi |10313991|ref|NC_002549.1|), or with a 5= overhang, as seen in the panhandle of some arenaviruses (31), remained inactive even after IFN priming (Fig. 5B) . Thus, the genome configurations detailed above may represent an efficient viral strategy to escape RIG-I activation.
One consequence of IFN-␤ priming is the increase of expression of interferon-stimulated genes (ISG), including that of RIG-I itself ( Fig. 5A and B, bottom panel) . Similar increases in RIG-I expression were observed under physiological conditions when cells were transfected with stimulatory RNAs (Fig. 5B, bottom  panel) . To examine whether this increased RIG-I expression was responsible for changing the minimum dsRNA length required for effective IFN-␤ stimulation (Fig. 5A ), A549 cells were transfected with plasmids expressing RIG-I prior to transfection with various duplexes. The results (Fig. 5C) show that both the 8r-12d and 10r-10d duplexes, inactive under unprimed conditions, induced IFN-␤ when RIG-I was overexpressed ectopically. Also, and as seen with IFN-␤ priming, RIG-I overexpression showed enhanced stimulation with the 20r and 30r duplexes (Fig. 5C ). The 2*5*r-18d duplex, which represents the minimal requirement for normal RIG-I ATPase activity, nevertheless remained largely inactive under the overexpressed RIG-I conditions (Fig. 5C ). Interestingly, its mirror molecule, 2*5*d-18r (with deoxynucleotides at positions 2 and 5 in an otherwise ribonucleotide-based backbone), exhibited decreased ATPase activity (Fig. 2H) and was inactive in inducing IFN-␤ under basal conditions (Fig. 5C ), highlighting once more the role of the ATPase in RIG-I activation.
The minimal length of dsRNA that activates RIG-I in unprimed cells is consistent with the formation of a 2-RIG-I/ dsRNA complex. According to the structural data, the dsRNA region of 10r-10d is sufficient to fully interact with one RIG-I molecule. However, this hybrid does not trigger IFN-␤ under unprimed conditions. One hypothesis to explain the minimal length beyond 10r (as dsRNA) required to activate RIG-I is that a 2-RIG-I/dsRNA complex is required (32) . We therefore performed electrophoretic mobility shift assays (EMSA) using our hybrid molecules. First, in contrast to the results seen with RNA pulldown, RIG-I binds to ssRNA in EMSA (Fig. 6D and data not  shown) . Only a 1-RIG-I/RNA complex is observed, and this likely reflects the capacity of the CTD to bind the 5= ppp group. The fact that this binding is seen only in EMSA could be due to the "caging effect," in which the tight environment of the acrylamide gel retains the link between RNA and protein even if this link is weak (33) . The 20r duplex, as well as the 2*5*r-18r duplexes, was found to bind two RIG-Is (Fig. 6A, B , and E), in contrast to the 20d, 2*5*r-18d, and 10r-10d hybrids, where the 1-RIG-I/RNA complex was mainly observed (Fig. 6A , B, C and E). As the total length of these hybrids is a constant 20 bp, RIG-I does not bind on RNA/ DNA hybrids other than at the 5= ppp end. No difference was observed in the presence or absence of the ATP and MgCl 2 needed for ATPase activity ( Fig. 6A ; see also Fig. S4A in the supplemental material). Moreover, two RIG-I ATPase mutants (K270A and D372A) also formed 2-RIG-I/RNA complexes with the same efficiency as the wt (see Fig. S4E ). Thus, in contrast to previously published data (34) , this complex formation is independent of ATPase activity, suggesting that RIG-I translocation is not involved in the formation of such duplexes (35) . As expected, the CARDs were dispensable (⌬N; see Fig. S4C ) but the CTD was absolutely required for binding, as complex formation was not observed with ⌬CTD RIG-I (⌬C, ⌬N⌬C; see Fig. S4C ) even in this very sensitive system. Interestingly, the CTD was also required for the binding of the second RIG-I, as no additional band corresponding to a heteroduplex RIG-I:RIG-I-⌬C/RNA was observed under conditions where a monomeric RIG-I/RNA complex was first made (see Fig. S4D ). Supershift experiments confirmed that this complex was specifically formed by RIG-I (see Fig. S4B ).
Increasing the length of the hybrid from 20 to 30 ribonucleotides only increased the efficiency of 2-RIG-I complex formation, without leading to binding of an additional RIG-I (Fig. 6C) . Upon further lengthening of the duplex to 40r and 60r, an additional complex, probably a 3-RIG-I/RNA complex, could now be observed (Fig. 6C) . Introducing a mismatch at the first position of a 30r duplex (30r mis.1, which alters the blunt-end nature of the ds structure) did not affect 2-RIG-I/RNA complex formation (Fig. 6C) . However, as in the presence of a 5= overhang, this duplex had slightly less ATPase activity (Fig. 2G ) and virtually no ability to induce IFN-␤ in vivo (Fig. 5B) . In EMSA, increasing the amount of RNA above that required for 2-RIG-I/RNA complex formation resulted in a decrease of the level of the 2-RIG-I/RNA complex in favor of the 1-RIG-I/RNA complex, probably due to an excess of the free 5= ppp ends that are preferentially bound (see the right panel in Fig. S4F in the supplemental material) . These results are consistent with the 2-RIG-I/RNA complexes effectively formed by the binding of 2 RIG-I molecules and were not due to a conformational change of a 1-RIG-I/RNA complex that altered its electrophoretic mobility.
Direct comparison of various hybrids for their abilities to form 2-RIG-I/RNA complexes in the presence of increasing amounts of RIG-I shows that the longer the ribonucleotide hybrid, the more efficient the 2-RIG-I/RNA complex formation (i.e., this complex was formed at lower RIG-I concentrations; Fig. 6B and C) . This may reflect the higher stability of such complexes. The length of these hybrids also correlates with their ability to induce IFN-␤ in our unprimed cells ( Fig. 3C ; see also Fig. S3B in the supplemental material). Taken together, these results indicate that for short dsRNAs, a minimum length of ribonucleotide duplex is required for 2-RIG-I/RNA complex formation and IFN-␤ activation. This complex formation requires the CTD but not the CARDs (see Fig. S4C ).
DISCUSSION
Taken together, our results and the available structural data allow us to refine a model for the contacts between the functional domains within RIG-I and a short 5= ppp-dsRNA (Fig. 7A ). In this model, RIG-I activation depends on the length of the dsRNA (Fig. 7B) . If a tetrameric RIG-I/RNA complex is the minimal structural requirement for activation (4), such a complex could be assembled as a single tetramer, 2 dimers, or 4 monomers, depending on the length of the dsRNA. The probability of forming such tetrameric complexes depends on the stability of the RIG-I/RNA complex, the rate of RIG-I recycling, and the RIG-I concentration.
RIG-I activation leading to IFN-␤ stimulation requires at least 3 steps: RNA recognition, ATPase activity, and exposure of the CARDs for downstream signaling. RIG-I oligomerization and binding to K63 polyubiquitin (poly-Ub) chains (mediated by TRIM25) are also part of this pathway (36) . Given the risk of an unintended autoimmune reaction, the entire activation mechanism must be tightly controlled. In our RNA pulldown assays, short dsRNAs, such as those present in viral RNA panhandle structures, are found to bind RIG-I because of their intrinsic double-stranded nature, independently of bottom strand composition (i.e., deoxy-or ribonucleotide; Fig. 1C and D) . A base-paired 5= ppp nucleotide is also Domains on the 5= ppp-dsRNA involved in binding to RIG-I, ATPase activity of RIG-I, and stability of the RIG-I/RNA complex are indicated. (B) Model of RIG-I activation depending on the length of the dsRNA. If a tetrameric RIG-I/RNA complex is the minimal structure required for RIG-I activation (42), 3 different scenarios (1 tetramer, 2 dimers, or 4 monomers) that are dependent on the length of the dsRNA can be envisaged. The probability of forming such tetrameric complexes depends on the stability of the RIG-I/RNA complex, including the rate of recycling of RIG-I in this complex. A direct consequence of this is that it also depends on the concentration of RIG-I within the cytoplasm.
required for RIG-I recognition, since a 5= overhang or a mismatch at position 1 decreases RIG-I binding (Fig. 1A and B and data not shown). The absence of binding in EMSA with the helicase domain alone (with or without the CARDs) highlights the importance of the CTD for RNA binding ( Fig. 7A ; see also Fig. S4C in the supplemental material) . Notably, this binding is also independent of ATP hydrolysis (see Fig. S1D ), in contrast to the dense loading of RIG-I onto longer dsRNAs to form RIG-I:dsRNA filaments (30, 34) . Based on crystal structures of RIG-I with or without dsRNA and a non-hydrolyzable form of ATP, the transition from autorepressed to activated RIG-I involves closure of its helicase domains upon binding dsRNA and ATP, which simultaneously disrupts the CARD:helicase interaction, as the CARDs and dsRNA bind in part to the same helicase surface. The closure of the helicase domains, however, creates a pocket not only for ATP binding but also for its hydrolysis. The function of this, the only known catalytic activity of RIG-I, is poorly understood. Although ATPase is essential for RIG-I signaling, there is nevertheless no strict correlation between the ability of various duplexes to stimulate the ATPase and their ability to induce IFN. Some duplexes, e.g., 10r-10d, stimulate the ATPase even more potently than pure dsRNA (20r) and yet are unable to induce IFN. Moreover, there is sometimes a seemingly contradictory negative relationship between stable RNA binding and ATPase induction; e.g., duplex mismatches decrease RIG-I activation but increase ATPase levels, again to levels above that of pure dsRNA (37) . A possible explanation of these unexpected findings is that, as the ATPase active site is formed by the closure of 2 helicase domains in coordination with dsRNA binding, if a rate-limiting step in ATP hydrolysis is removal of ADP and P i from the active site, duplex instability due to mismatches or deoxyribonucleotides can also increase ATPase levels by facilitating the discharge of ADP and P i from the active site. ATP turnover is thus enhanced, increasing ATPase activity. Thus, in some cases, weaker duplex binding can apparently be more than compensated for by increased ATP turnover, leading to enhanced ATPase activity. In line with this, we show that ATPase increased RIG-I recycling (Fig. 4) .
As ATPase is also required for RIG-I activation, this may appear incompatible with the ATPase recycling activity. One way to reconcile these two roles of the ATPase (essential for activation and for RNA recycling) is to postulate that there is a competition between recycling and RIG-I oligomerization. This competition may be particularly important for short dsRNAs that are similar to self-RNAs. RIG-I complex formation depends on the length of the duplex (in agreement with references 4 and 34) and RIG-I abundance. Very short (8-to 12-bp) dsRNAs require higher concentrations of RIG-I for complex formation and activation, presumably because recycling outweighs complex formation. When the dsRNA is even shorter, i.e., indistinguishable from self-RNAs, recycling always prevails and RIG-I is never activated. ATPase activity is presumably responsible for the same RIG-I conformational changes needed for both complex formation and recycling. If a RIG-I tetrameric complex is not formed (RNA too short, RIG-I concentration too low), ATPase leads to recycling. If a RIG-I oligomeric complex is formed (longer RNA, higher concentration of RIG-I), RIG-I is not recycled, presumably because the complex is stable. In this way, the presence of ATPase leads to the formation of stable, active complexes. However, none of the circumstances outlined above exclude the possibility that ATP hydrolysis is required for other functions in IFN induction.
Given the abundance of cellular RNAs and the serious risk that inappropriate induction of IFN can lead to an autoimmune response, RIG-I signaling must be very tightly controlled, occurring only when confronted with non-self-RNA. Should self-RNA be bound, however infrequently, there is likely to be a mechanism to free this RIG-I from its inappropriate ligand, and the finding that ATP hydrolysis promotes RIG-I exchange on preformed RIG-I: dsRNA complexes (Fig. 4) is likely to be germane in this context. This exchange is possible presumably because the RNA is less tightly bound to the helicase in the absence of the ATP that helps to maintain its closure. One function of the RIG-I ATPase would then be to dissociate RIG-I from inappropriate ligands, as well as from those with a dsRNA less than 13 bp in length in unprimed cells (see below). The fact that duplexes with reduced stability (a possible indicator of self-RNAs) more strongly stimulate the ATPase is in line with this exchange function of RIG-I.
The minimum length of dsRNA required for IFN-␤ stimulation is still a subject of debate, with estimates ranging from 10 bp (11) to 19 bp (10). Recently, two groups reported that dsRNAs as short as 10 bp, a length that can accommodate only one RIG-I, can activate IFN-␤ (38, 39) . These experimental differences can have several explanations. The structures of the RNAs used in the latter studies were different, as the Goulet and Kohlway groups used RNAs with stem-loop structures, which might affect stability of the RIG-I:RNA complex, especially within cells. Our experiments suggest that variations in cellular RIG-I concentrations of cultured cells could also explain these divergent results. Even 1-RIG-I/10r-10d duplexes can oligomerize in trans, to form the essential tetrameric RIG-I/poly-Ub chain complex (Fig. 7B, left panel) , but this would require higher RIG-I concentrations than those required for 2-RIG-I/20r duplexes or longer duplexes (as found in Fig. 5 ), especially as RIG-I on 10r-10d duplexes recycles more rapidly than RIG-I on 20r duplexes (Fig. 7B, middle panel) . The notion that the minimum length of dsRNA required for IFN induction can be modified by cellular RIG-I concentrations is suggested by the finding that when our cells were primed, i.e., pretreated with IFN-␤ before RNA transfection, short duplex molecules such as 9r-11d, 10r-10d, 11r-9d, and 12r-8d, which are inactive in unprimed cells, became active (Fig. 5A and B and data not shown). One consequence of this priming is the increased expression of RIG-I, as RIG-I itself is an ISG (Fig. 5) . A similar result was obtained with RIG-I overexpression, which apparently also brings about a qualitative shift in the nature of the RNA recognized as a PAMP (Fig. 5C ). When RIG-I concentrations increase, formation of active tetrameric RIG-I complexes is favored, mainly for very short dsRNAs (between 8 and 12 bp in length) that carry only one RIG-I and are presumably more prone to RIG-I recycling (Fig. 7B) .
This scheme is consistent with the notion that uninfected cells need to be highly selective in recognizing RNAs as PAMPs, so as to discriminate between self-RNA and non-self-RNAs. Once RIG-I is activated upon viral infection and IFN produced, the increased levels of PRRs render cells less discriminatory toward PAMPs but more efficient in mounting an antiviral response.
contains the Renilla luciferase gene (Promega) driven by the herpes simplex virus TK promoter. pEBS-tom encodes a red fluorescent protein. pET28-His10Smt3 containing a wt or mutant human RIG-I gene was engineered as described previously (24) .
In vitro RNA synthesis. The template for T7 RNA polymerase synthesis of 5= ppp-ssRNA (top strand) was prepared by annealing oligonucleotides as follows: 5=-TAATACGACTCACTATAgcgcaccggggaaccaaggcgaac acggacacgcaacaaacgagaccgacaacagacagga, representing the T7 polymerase promoter (bold) and the Ϫ1 to ϩ59 junin virus 5= RNA sequence (lowercase) in which U residues at the underlined positions were replaced by the indicated nucleotides to prevent synthesis of double-stranded RNA in a T7 polymerase reaction mixture lacking U residues, and its complementary oligonucleotide, and 5=-tcctgtctgttgtcggtctcgtttgttgcgtgtccgtgttcgcctt ggttccccggtgcgcTATAGTGAGTCGTATTA.
After annealing, dsDNAs were purified with a QIAquick PCR purification kit (Qiagen) and 12 pmol was used for the in vitro transcription performed with T7 MEGAshortscript (Ambion) according to the manufacturer's instructions (in the absence of UTP). Biotinylated ssRNA was obtained by T7 polymerase transcription in the presence of a 3:1 molar ratio of CTP and biotin-11-CTP (Roche 04739205001). Radiolabeled ssRNA was obtained by T7 polymerase transcription in the presence of a 50:1 molar ratio of CTP and [␣-32 P]CTP (Hartmann Analytic). Fluorescent ssRNA was obtained by performing in vitro transcription in the presence of a 2:3 molar ratio of CTP and cyanine 5-CTP (PerkinElmer NEL581001EA).
To obtain 5= OH-ssRNA, in vitro transcripts were treated with alkaline phosphatase (Roche 11097075001) according to the manufacturer's instructions. Total T7 transcripts were digested with turbo DNase for 15 min at 37°C and purified on NucAway Spin columns (Ambion) to remove unincorporated nucleotides and DNA fragments. Double-stranded RNA preparation. 5= ppp-ssRNA or 5= OH-ssRNA (synthetic or obtained by alkaline phosphatase treatment) was mixed with the indicated synthetic complementary 5= OH oligoribonucleotides in a 1 to 2 M ratio in a final volume of 100 l (300 mM NaCl, 50 mM Tris [pH 7.5], 1 mM EDTA), heated 1 min at 95°C, and progressively cooled to room temperature (RT).
Transfection and measurement of IFN-␤ promoter activity. A549 cells (human alveolar adenocarcinoma cell line) were grown in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum and 1% penicillin-streptomycin (Pen/Strep). A total of 100,000 cells were plated into 6-well plates and were transfected 24 h later with 1.5 g of p␤-IFN-fl-lucter, 0.5 g of pTK-rl-lucter, and 0.5 g of pEBS-tom (used as a transfection control), using Gene Juice transfection reagent (Novagen). Twenty-four hours later, cells were transfected (or not) with 400 ng (or as otherwise indicated) of 5= ppp-dsRNA using TransMessenger transfection reagent (Qiagen) according to the manufacturer's instructions. Twenty hours later, cells were harvested and cell lysates were used to measure firefly and Renilla luciferase activity (dual-luciferase reporter assay system, Glomax 20/20 luminometer; Promega).
Recombinant RIG-I expression. The pET28-His10Smt3-RIG-I wt or mutant plasmids were transformed into Escherichia coli BL21 cells. Cultures (500 ml) derived from single transformants were grown at 37°C in LB medium containing 50 g/ml kanamycin to an OD600 of 0.6. The cultures were adjusted to 0.2 mM IPTG (isopropyl-␤-D-thiogalactopyranoside) and 2% ethanol and further incubated for 20 h at 17°C. Cells were harvested by centrifugation, and recombinant RIG-I protein was purified from bacteria as previously described (24) . Protein concentrations were determined using the Bio-Rad dye-binding method with bovine serum albumin (BSA) as the standard.
RNA pulldown assay. Strepavidin agarose beads (Invitrogen SA100-04) were preequilibrated with blocking buffer (base buffer [20 mM HEPES {pH 7.9}, 15% glycerol, 0.05% Nonidet P-40, 50 mM NaCl, 0.2 mg/ml tRNA; Roche Applied Science, 10109495001], and 2 mM dithiothreitol [DTT]) plus 100 mM NaCl, 0.1 mg/ml glycogen, and 5 mg/ml BSA for 2 h at 4°C. For each assay, 13 pmol of biotinylated RNA was incubated with the beads in binding buffer (base buffer plus 2 mM DTT, 1% protease inhibitor mixture [Sigma, P8340], and 100 U/ml RNasin [Promega N2515]) for 2 h at 4°C. After two washes with washing buffer (base buffer plus 2 mM DTT and 0.05 mg/ml tRNA), the beads were incubated with 1.25 g (12 pmol) of purified recombinant RIG-I in binding buffer with or without 2 mM MgCl 2 and 0.5 mM ATP as indicated. After 15 min at 37°C, the beads were washed three times with washing buffer followed by elution in SDS protein sample buffer. The reactions were analyzed by Western blotting probing the membrane with anti-RIG-I antibody.
Electrophoretic mobility shift assay. Increasing amounts of purified recombinant RIG-I were incubated with 250 nM radiolabeled RNA in a final volume of 20 l (20 mM HEPES [pH 7.5], 75 mM NaCl, 2.5 mM MgCl 2 , 2 mM DTT, 1 mM ATP) for 30 min at RT. After addition of 5ϫ native loading buffer (300 mM Tris [pH 6.8], 50% glycerol, 0.05% bromophenol blue), reactions were analyzed on Tris-borate-EDTA (TBE) acrylamide 4% to 12% gradient nondenaturing gel. The radioactivity was revealed by phosphorimaging (Typhoon; GE Healthcare Life Sciences).
Measurement of RIG-I ATPase activity. Increasing amounts (4 to 250 nM) of various RNA molecules were incubated with 200 nM purified recombinant RIG-I and [␥-32 P]ATP (Hartmann Analytic) in a final volume of 15 l (50 mM Tris acetate [pH 6], 5 mM DTT, 1.5 mM MgCl 2 ) for 15 min at 37°C. Reactions were then stopped with 1 mM formic acid, and 2.5 l of each reaction mixture was spotted onto TLC PEI cellulose F plates (Merck 1.05579.0001) and applied to a migration buffer (0.5 M LiCl, 1 N formic acid) to separate released 32 PO 4 and non-hydrolyzed ATP. 32 PO 4 release was measured in a phosphorimager (Typhoon; GE Healthcare Life Sciences) and quantified with ImageQuantTL software (GE Healthcare Life Sciences).
Transfection and measurement of IFN-␤ promoter activity. A549/ pr(IFN-␤) GFP reporter cells (41) were transfected as described above. Twenty hours later, GFP expression was monitored and pictures were acquired using an Evos FL epifluorescence microscope. Twentyfour hours posttransfection, cells were harvested and the percentage of GFP-positive cells was determined by flow cytometry on 20,000 cells (i.e., 10% of the harvested cells) using a BD Accuri C6 Cytometer. Data were analyzed using CFlow Plus software (Accuri, version 1.0.264.15).
Antibodies. The following primary antibodies were used: anti-RIG-I (Alexis 210-932C100) (1:1,000) and anti-His (H1029; Sigma) (1:2,000). Immunoblot analyses were developed with the following secondary antibody: anti-mouse IgG horseradish peroxidase-conjugated whole antibody (Bio-Rad) (1:3,000).
Statistical analysis. Unpaired t tests were performed using GraphPad Prism version 6.00 (GraphPad Software).
Quantifications. Western blot quantifications were performed using ImageJ version 1.44p (W. S. Rasband; ImageJ, U. S. National Institutes of Health, Bethesda, MD, http://imagej.nih.gov/ij/, 1997 to 2014).
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